What is in a Blood Group? ABO and Rh Blood Types in COVID–19: Correlation with Clinical Outcomes in A Tertiary Care Centre in India

Authors

  • Aparna Muralidhar Assistant Professor, Department of Pathology, Dr.Chandramma Dayananda Sagar Institute of Medical Education and Research, Harohalli Ramanagara, Karnataka, India
  • Archana Shetty Associate Professor & Blood Transfusion Officer, Department of Pathology, Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Harohalli Ramanagara, Karnataka, India
  • Nidha Gaffoor Assistant Professor, Department of Pathology, Dr.Chandramma Dayananda Sagar Institute of Medical Education and Research, Harohalli Ramanagara, Karnataka, India.
  • Supriya Sandeepa Associate Professor, Department of Pathology, Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Harohalli Ramanagara, Karnataka, India
  • Kanna Sandhyarani Assistant Professor, Department of Pathology, Dr.Chandramma Dayananda Sagar Institute of Medical Education and Research, Harohalli Ramanagara, Karnataka, India
  • Bhargavi Kalburgi Nagabhushan Assistant Professor, Department of Pathology, Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Harohalli Ramanagara, Karnataka, India

DOI:

https://doi.org/10.31344/ijhhs.v6i4.483

Keywords:

Blood group antigens, COVID-19 pandemic, Coronavirus

Abstract

Background: COVID-19 pandemic has immensely burdened healthcare. Susceptibility and severity of infection though largely determined by an individual’s immunity, age and comorbidities; however, recent literature reported that ABO blood type might be a contributory factor by virtue of its antigenic properties.

Objective: To explore the distribution of ABO & Rh blood types in COVID -19 patients and correlate the same with clinical severity and mortality.

Methods: This retrospective study was conducted from May 2020 to September 2021 at a tertiary care centre. Data of ABO & Rh blood type of COVID-19 patients admitted to our hospital was collected. Details on severity and mortality was obtained from hospital database. Pearson’s chi square test was used to compare categorical data. p-value<0.05 was considered statistically significant.

Results: A total of 548 cases were included, with mean age of 48.8 ±7.1 years and male predominance. O positive (45.1%) and A negative (0.7%) were most and least frequently affected respectively. Majority were Rh positive (96.0%). 143 were severely ill requiring intensive care. Among the fifty-six deceased, most belonged to O blood group. No significant association was observed between blood type with severity/mortality.

Conclusion: ABO blood type cannot be a pivotal biomarker for predicting COVID-19 associated severity and mortality. With limited literature in this field revealing diverse findings, a definitive association between blood type and COVID-19 is challenging. This may indicate unexplored underlying contributing factors, not necessarily blood group or type of antibodies present.

International Journal of Human and Health Sciences Vol. 06 No. 04 Oct’22 Page: 432-437

Downloads

Published

2022-09-18

How to Cite

Muralidhar, A., Shetty, A., Gaffoor, N., Sandeepa, S., Sandhyarani, K., & Nagabhushan, B. K. (2022). What is in a Blood Group? ABO and Rh Blood Types in COVID–19: Correlation with Clinical Outcomes in A Tertiary Care Centre in India. International Journal of Human and Health Sciences (IJHHS), 6(4), 432–437. https://doi.org/10.31344/ijhhs.v6i4.483

Issue

Vol. 6 No. 4 (2022)

Section

Original Articles

License

Copyright (c) 2022 Aparna Muralidhar, Archana Shetty, Nidha Gaffoor, Supriya Sandeepa, Kanna Sandhyarani, Bhargavi Kalburgi Nagabhushan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the International Journal of Human and Health Sciences agree to the following terms that:

  1. Authors retain copyright and grant International Journal of Human and Health Sciences the right of first publication of the work.

  2. Creative Commons Licence
    Articles in International Journal of Human and Health Sciences are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.